R&D channel feed – Endpoints News

R&D channel feed

Protagonist reports a PhII fail in ulcerative colitis, but execs are pushing forward anyway

4 years ago

CRL appeal lands Ardelyx an FDA adcomm meeting for embattled CKD drug

4 years ago

Axolotls, chemical cocktails, and a new route for stem cell therapy — maybe

4 years ago

Black Diamond lays off 30% of its workforce and culls a drug from its 'MasterKey' chest

4 years ago

Faheem Hasnain acknowledges another setback for the Gossamer pipeline, but investors aren't panicking

4 years ago

'Results are unambiguous': Eliem's lead program fails and share price halves before opening bell

4 years ago

Nkarta reveals its first off-the-shelf NK cell data, showing multiple complete responses — shares soar

4 years ago

Roche hit with another key R&D setback as oral SERD flops in breast cancer

4 years ago

New paper sheds fresh light on Tmunity's high-profile CAR-T deaths

4 years ago

Scynexis builds out case for its antifungal in the hospitalized setting, but investors don't seem happy

4 years ago

Astellas writes off $560M loss, dropping gene therapy programs, oncology antibody

4 years ago

Microcap biotech seeks a merger or new investment after PhIII flop — shares soar

4 years ago

Bayer plucks another oncology exec away from GlaxoSmithKline as it continues prostate cancer push

4 years ago

How Novartis assesses a drug's probability of success prior to the pivotal trial

4 years ago

Sanofi offloads two late-stage drugs to virtually unknown neuro and psychedelic biotech

4 years ago

Orasis will ship its Vuity eye drop competitor to the FDA later this year with two PhIII wins

4 years ago

Still struggling to get an EUA, Novavax paints early rosy picture of combo Covid-19/flu vaccine

4 years ago

Arcturus slides on PhIII Covid-19 vaccine data, signifying the struggle in producing follow-up shots

4 years ago

Citing 'strategic considerations,' AbbVie breaks off Parkinson's deal with biotech partner

4 years ago

Teva receives CRL for reformulated schizophrenia drug developed with French biotech

4 years ago

Covid-19 roundup: Moderna showcases progress on its bivalent booster; Novavax wins approval in Japan

4 years ago

OrbiMed-backed biotech looks to challenge Vertex in cystic fibrosis by 'drugging the undruggable'

4 years ago

Acadia's prized pain drug from $52M buyout flops its first test

4 years ago

Regeneron buys Art Krieg’s biotech startup for a discount price, boosting I/O pipeline

4 years ago

First page Previous page 138 139 140141142 143 144 Next page Last page